Exagen (XGN) Payables (2018 - 2026)

Exagen (XGN) has 9 years of Payables data on file, last reported at $4.2 million in Q1 2026.

• Quarterly Payables fell 7.76% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 7.76% YoY) and the FY2025 annual result came in at $4.2 million, changed 0.39% from the prior year.
• Payables held at $4.2 million in Q1 2026, from $4.2 million in the prior quarter.
• In the past five years, Payables ranged from a high of $4.5 million in Q1 2025 to a low of $1.1 million in Q3 2024.
• A 5-year average of $2.9 million and a median of $3.1 million in 2022 frame the typical range for Payables.
• Annual changes were most pronounced in 2023 — Payables sank 57.84% — and 2025, when it jumped 222.08%.
• Tracing XGN's Payables over 5 years: stood at $3.0 million in 2022, then advanced by 2.79% to $3.1 million in 2023, then soared by 32.13% to $4.1 million in 2024, then climbed by 0.39% to $4.2 million in 2025, then advanced by 0.14% to $4.2 million in 2026.
• The last three Payables figures came in at $4.2 million (Q1 2026), $4.2 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.